Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company SiteOne Therapeutics Inc.
DescriptionPET imaging agent
Molecular Target Nav1.7 (SCN9A) ; Sodium channel
Mechanism of ActionDiagnostic; Imaging agent
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPreclinical
Standard IndicationNeurology, Diagnostic
Indication DetailsIdentify pain generators in chronic and neuropathic pain patients
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today